Henoch-Schonlein Purpura - Sally Daughtrey, ND (2021 Conference) (LDN, low dose naltrexone)

In her presentation, Dr. Daughtry explains Henoch-Schonlein (HSP), its triggers and complications (such as serious hidden infections often missed initially), and the use of Low Dose Naltrexone in treating HSP. Dr. Daughtry gives an in-depth look into one pediatric case she treated successfully with LDN.

A Curious Case Study: When the only solution is Skull-Reconstruction - Elizabeth Livengood, NMD (2021 Conference) (LDN, low dose naltrexone)

Tom O’Bryan, DC, CCN, DACBN - Dietary Triggers of Pain and Inflammation (2016 Conference) (LDN, low dose naltrexone)

Download Dr. O'Bryan's Dietary Triggers Presentation

Galyn Forster, MS, LPC - Treatment of Psychiatric Disorders (2016 Conference) (LDN, low dose naltrexone)

Download Mr. Forster's Psych Disorders Presentation

Lachlan Cox - Clinical Hypnosis and Pain Control (2016 Conference) (LDN, low dose naltrexone)

Download Lachlan Cox's Hypnosis Presentation

Pradeep Chopra, MD - Chronic Pain, Opioids and LDN (2016 Conference) (LDN, low dose naltrexone)

Download Dr. Chopra's Pain Presentation

Opiate Receptor Drugs – To Cycle or Not to Cycle Dosing? - Paul Anderson, NMD (2021 Conference) (LDN, low dose naltrexone)

Mold toxicity - Leonard Weinstock, MD (2021 Conference) (LDN, low dose naltrexone)

Drug Resistant Depression - Elizabeth Livengood, NMD (2021 Conference) (LDN, low dose naltrexone)

Dr. Elizabeth Livengood’s presentation is on identifying different causes of depression, identifying depression, hyperthyroidism connections, identifying patient profiles who fit these descriptions, and understanding how to treat them. 

Pain - Samyadev Datta, MD (2021 Conference) (LDN, low dose naltrexone)

LDN Research Trust 2021 Conference - Friday Morning